News & Publications

Kelly Garneski joins the lab to work on the molecular and genetic alterations in MCC. She is an MSTP student who will join the lab for her doctoral work.

Dr. Xiaohui Bi joins the lab to work on molecular and biological studies of Merkel cell carcinoma.  She will use high resolution array-comparative genomic hybridization (CGH) to discover chromosomal copy number alterations  (CNAs) that may indicate tumor suppressors (loss of region) and oncoge...

Discussion/support group begun by a patient at "Google Groups". Click here for more information.

New study of 251 patients from Memorial Sloan-Kettering Cancer Center in New York concluded that: Stage at presentation was an independent predictor of survival. Patients with pathologically negative lymph node involvement have an excellent prognosis Suggested that there is no survival be...

Dr. Nghiem received funding from the Harvard Skin Cancer SPORE to maintain a clinical database and tumor bank. In addition, he will be leading genetic studies to futher understand the biology of MCC.

Dr. Pablo Penas joins the lab from Madrid Spain for 6 months.  He will focus on the clinical database and preparing DNA samples from MCC tumor specimens for genetic analysis using comparative genomic hybridization.  In Madrid he is a dermatologist who runs a basic science lab.

Dr. Martina Gellenthin, dermatology resident from Berlin joins the Merkel cell effort at Harvard.  She brings experience in skin cancer database management from her fellowship program in Berlin.  She will focus on creating a database for our ~150 Merkel cell carcinoma patients at Brigham and W...

Dana-Farber patient makes first gift to Merkel cell carcinoma effort

We're celebrating the launch of this website, merkelcell.org, the first to focus on Merkel cell carcinoma.